We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
BIO-RAD LABORATORIES

Download Mobile App




Social Network for Diagnostics Launched

By LabMedica International staff writers
Posted on 01 Mar 2015
Print article
Image: DiaDome target groups (Photo courtesy of DiaDome).
Image: DiaDome target groups (Photo courtesy of DiaDome).
A social network is specifically designed for business interaction in field of diagnostics has been started.

DiaDome (Germany) is a newly developed social network designed specifically for the field of diagnostics. It relies on user generated content; it eliminates individual personal interests and replaces them with those of the organization. DiaDome combines the ease of online communications of a social network with all features necessary for a professional business interaction. Segmentation into three equal parts, clinical, food & feed and veterinary, creates an expert environment for its members.

The diagnostics sector has distinct requirements. Facebook, for example, is too broad and small and medium-sized diagnostic organizations get easily overlooked in a crowded environment. On the other hand, LinkedIn is very good for individual careers. Recruiting is one of the major advantages for individuals but again, for diagnostic companies and organizations features are limited and the noise of information can be overwhelming.

A major difference is that DiaDome is based only on organizational profiles. Thus, individual interests get excluded and the interests of organizations as a whole are in focus. There is no recruiting on DiaDome and personal careers are not in focus. Organizations present themselves with their profile, offer their products and services and connect with their business partners, suppliers and customers. Additionally, organizations can create as many user accounts as needed for their profile for optimal use of DiaDome. Also, DiaDome is a special interest network for the field of diagnostics only. This way, an expert environment is created.

DiaDome, a website based in Germany, is currently live. Organizations are already able to register and use DiaDome to full extent. The website is intuitively laid out, and safe and secure. The basic membership is free and all new members enjoy a 3-month free trial period to use DiaDome with all its features.

Related Links:

DiaDome


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
Gold Member
Plasma Control
Plasma Control Level 1

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: A blood test could predict lung cancer risk more accurately and reduce the number of required scans (Photo courtesy of 123RF)

Blood Test Accurately Predicts Lung Cancer Risk and Reduces Need for Scans

Lung cancer is extremely hard to detect early due to the limitations of current screening technologies, which are costly, sometimes inaccurate, and less commonly endorsed by healthcare professionals compared... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The real-time multiplex PCR test is set to revolutionize early sepsis detection (Photo courtesy of Shutterstock)

1 Hour, Direct-From-Blood Multiplex PCR Test Identifies 95% of Sepsis-Causing Pathogens

Sepsis contributes to one in every three hospital deaths in the US, and globally, septic shock carries a mortality rate of 30-40%. Diagnosing sepsis early is challenging due to its non-specific symptoms... Read more

Pathology

view channel
Image: The QIAseq xHYB Mycobacterium tuberculosis Panel uses next-generation sequencing (Photo courtesy of 123RF)

New Mycobacterium Tuberculosis Panel to Support Real-Time Surveillance and Combat Antimicrobial Resistance

Tuberculosis (TB), the leading cause of death from an infectious disease globally, is a contagious bacterial infection that primarily spreads through the coughing of patients with active pulmonary TB.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.